HealthEquity Inc (HQY)

Total asset turnover

Jan 31, 2025 Oct 31, 2024 Jul 31, 2024 Apr 30, 2024 Jan 31, 2024 Oct 31, 2023 Jul 31, 2023 Apr 30, 2023 Jan 31, 2023 Oct 31, 2022 Jul 31, 2022 Apr 30, 2022 Jan 31, 2022 Oct 31, 2021 Jul 31, 2021 Apr 30, 2021 Jan 31, 2021 Oct 31, 2020 Jul 31, 2020 Apr 30, 2020
Revenue (ttm) US$ in thousands 1,203,871 1,153,288 1,088,356 1,018,339 958,410 916,132 884,134 848,438 815,511 788,427 748,466 735,565 717,815 706,638 714,959 700,254 700,489 719,841 694,134 614,980
Total assets US$ in thousands 3,448,550 3,488,350 3,514,470 3,246,480 3,163,790 3,093,500 3,066,460 3,035,010 3,088,900 3,064,760 3,074,020 3,065,070 3,107,100 3,099,610 3,148,630 3,161,870 2,710,410 2,657,260 2,664,380 2,562,480
Total asset turnover 0.35 0.33 0.31 0.31 0.30 0.30 0.29 0.28 0.26 0.26 0.24 0.24 0.23 0.23 0.23 0.22 0.26 0.27 0.26 0.24

January 31, 2025 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $1,203,871K ÷ $3,448,550K
= 0.35

The total asset turnover of HealthEquity Inc has been gradually improving over the period from April 2020 to January 2025. The ratio increased from 0.24 in April 2020 to 0.35 in January 2025. This indicates that the company is generating more revenue relative to its total assets, which is a positive sign of efficiency in asset utilization.

There were fluctuations in the total asset turnover ratio throughout the period, with some quarters showing slight decreases or increases. However, the overall trend shows steady improvement over time, with the ratio consistently trending upwards.

A total asset turnover ratio of 0.35 as of January 2025 suggests that for every dollar of total assets, HealthEquity Inc generates $0.35 in revenue. This indicates that the company is effectively using its assets to generate sales, which is important for profitability and sustainable growth.

Overall, the trend of increasing total asset turnover ratio signifies that HealthEquity Inc has been able to enhance its operational efficiency and effectively utilize its assets to drive top-line growth.